Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 207

1.

Feasibility of postexposure prophylaxis (PEP) against human immunodeficiency virus infection after sexual or injection drug use exposure: the San Francisco PEP Study.

Kahn JO, Martin JN, Roland ME, Bamberger JD, Chesney M, Chambers D, Franses K, Coates TJ, Katz MH.

J Infect Dis. 2001 Mar 1;183(5):707-14. Epub 2001 Feb 1.

2.

Human immunodeficiency virus postexposure prophylaxis for adolescents and children.

Merchant RC, Keshavarz R.

Pediatrics. 2001 Aug;108(2):E38.

PMID:
11483848
3.

Seroconversion following nonoccupational postexposure prophylaxis against HIV.

Roland ME, Neilands TB, Krone MR, Katz MH, Franses K, Grant RM, Busch MP, Hecht FM, Shacklett BL, Kahn JO, Bamberger JD, Coates TJ, Chesney MA, Martin JN.

Clin Infect Dis. 2005 Nov 15;41(10):1507-13. Epub 2005 Oct 13.

4.

Use of postexposure prophylaxis against HIV infection following sexual exposure does not lead to increases in high-risk behavior.

Martin JN, Roland ME, Neilands TB, Krone MR, Bamberger JD, Kohn RP, Chesney MA, Franses K, Kahn JO, Coates TJ, Katz MH.

AIDS. 2004 Mar 26;18(5):787-92.

PMID:
15075514
5.

Tolerability of postexposure prophylaxis with zidovudine, lamivudine, and nelfinavir for human immunodeficiency virus infection.

Rabaud C, Bevilacqua S, Beguinot I, Dorvaux V, Schuhmacher H, May T, Canton P.

Clin Infect Dis. 2001 May 15;32(10):1494-5. Epub 2001 Apr 18.

6.

[Recommendations for non-occupational postexposure HIV prophylaxis. Spanish Working Group on Non-Occupational Postexposure HIV Prophylaxis of the Catalonian Center for Epidemiological Studies on AIDS and the AIDS Study Group].

Almeda J, Casabona J, Allepuz A, García-Alcaide F, del Romero J, Tural C, Colm J, Bolao F, Campins M, Domínguez A, Force L, Giménez A, Guerra-Romero L; Grupo de Consenso Español sobre Profilaxis Postexposición No Ocupacional al VIH.

Enferm Infecc Microbiol Clin. 2002 Oct;20(8):391-400. Review. Spanish.

PMID:
12372236
7.

Cost-effectiveness of postexposure prophylaxis after sexual or injection-drug exposure to human immunodeficiency virus.

Pinkerton SD, Martin JN, Roland ME, Katz MH, Coates TJ, Kahn JO.

Arch Intern Med. 2004 Jan 12;164(1):46-54.

PMID:
14718321
8.

Postexposure prophylaxis for human immunodeficiency virus infection after sexual or injection drug use exposure: identification and characterization of the source of exposure.

Roland ME, Martin JN, Grant RM, Hellmann NS, Bamberger JD, Katz MH, Chesney M, Franses K, Coates TJ, Kahn JO.

J Infect Dis. 2001 Dec 15;184(12):1608-12. Epub 2001 Dec 3.

9.

Post-exposure prevention (PEP) for sexual, needle exposure opens in New York.

[No authors listed]

AIDS Treat News. 2000 Jan 21;(No 335):6-7.

PMID:
11367204
10.

HIV postexposure prophylaxis for children and adolescents.

Babl FE, Cooper ER, Damon B, Louie T, Kharasch S, Harris JA.

Am J Emerg Med. 2000 May;18(3):282-7.

PMID:
10830685
11.

Serious adverse events attributed to nevirapine regimens for postexposure prophylaxis after HIV exposures--worldwide, 1997-2000.

Centers for Disease Control and Prevention (CDC).

MMWR Morb Mortal Wkly Rep. 2001 Jan 5;49(51-52):1153-6.

12.

Non-occupational postexposure prophylaxis for HIV: a systematic review.

Bryant J, Baxter L, Hird S.

Health Technol Assess. 2009 Feb;13(14):iii, ix-x, 1-60. doi: 10.3310/hta13140. Review.

13.

Cost-effectiveness of post-exposure prophylaxis following sexual exposure to HIV.

Pinkerton SD, Holtgrave DR, Bloom FR.

AIDS. 1998 Jun 18;12(9):1067-78.

PMID:
9662204
14.

The Danish PEP registry: experience with the use of postexposure prophylaxis (PEP) following sexual exposure to HIV from 1998 to 2006.

Lunding S, Katzenstein TL, Kronborg G, Lindberg JA, Jensen J, Nielsen HI, Pedersen C, Jørgensen LB.

Sex Transm Dis. 2010 Jan;37(1):49-52. doi: 10.1097/OLQ.0b013e3181b6f284.

PMID:
19734819
16.

Cost-effectiveness of HIV postexposure prophylaxis following sexual or injection drug exposure in 96 metropolitan areas in the United States.

Pinkerton SD, Martin JN, Roland ME, Katz MH, Coates TJ, Kahn JO.

AIDS. 2004 Oct 21;18(15):2065-73.

PMID:
15577628
17.
18.

Study follows PEP for sexual exposures.

[No authors listed]

AIDS Alert. 1998 Sep;13(9):106-7.

PMID:
11365790
19.

[Post-exposure HIV prevention within and outside the hospital].

Jost J.

Ther Umsch. 1998 May;55(5):289-94. Review. German.

PMID:
9643126
20.

PEPping up your HIV defenses.

Torres G.

GMHC Treat Issues. 1998 May;12(5):8-9.

PMID:
11365480
Items per page

Supplemental Content

Write to the Help Desk